As a courtesy to our forum of advocacy in immune modulation in critically ill patients (AIMC), Urihk Pharmaceuticals held a webinar on immunomodulators in critical illness. The webinar highlights the latest treatment options in critical illnesses and their role in improving outcomes.
Dr. Kapil Zirpe, HOD Neuro Trauma Unit, Grant Medical, and Ruby Hall Clinic, Pune expertly hosted the webinar on the topic of Immunomodulators in critical illness. The webinar was well attended by various critical care physicians and healthcare professionals across Maharashtra. The speakers were renowned doctors from the field and they shared their insights on the best practices for treating patients.
Dr. Subhal Dixit, Director Critical Care – Sanjeevan &MJM Hospital, Pune. And Dr. Abdul Ansari, Director Critical Care- Nanavati Hospital, Mumbai were the pioneer speakers during the event who discussed Immune Dysregulation and Therapeutic Approach: Sepsis, ARDS, and Covid 19.
Further, A panel discussion, which aimed to cover crucial topics related to Sepsis, ARDS, and COVID 19 and discuss the latest trends in critical care medicine and explored how medical practice can be benefited. This discussion was led by eminent panelist members Dr. Rajan Barokar, Director -Department of Critical Care and Emergency medicine, Kingsway Hospital Nagpur. Dr. Anand Nikalje Director-MCRI ICU, Associate professor Medicine MGM Medical College and Hospital Aurangabad. Dr. Nirmal Taparia, Assistant Professor- Ashwini Rural Medical College, Solapur
